 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$0.10 |
$0.14 |
$0.10 |
$0.12 |
115.11M | | 04/16/2024 |
$0.15 |
$0.26 |
$0.14 |
$0.18 |
616.38M | | 04/17/2024 |
$0.18 |
$0.21 |
$0.15 |
$0.17 |
133.95M | | 04/18/2024 |
$0.14 |
$0.18 |
$0.14 |
$0.18 |
69.32M | | 04/19/2024 |
$0.16 |
$0.17 |
$0.15 |
$0.16 |
30.39M |
|
|
| Jaguar Health is a pharmaceuticals company that develops plant-based, sustainably derived prescription medicines for people and animals with gastrointestinal distress, such as chronic, debilitating diarrhea. Co.'s subsidiary, Napo Pharmaceuticals, Inc. (Napo), develops and commercializes proprietary plant-based human pharmaceuticals. Napo's marketed drug Mytesi (crofelemer 125 mg delayed-release tablets) is an oral botanical drug product for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Co.'s Canalevia-CA1 (crofelemer delayed-release tablets) drug is an oral plant-based prescription product to treat chemotherapy-induced diarrhea in dogs. | |
|
Jaguar Health (JAGX) has the following price history information. Looking back at JAGX historical stock prices for the last five trading days, on April 15, 2024, JAGX opened at $0.10, traded as high as $0.14 and as low as $0.10, and closed at $0.12. Trading volume was a total of 115.11M shares. On April 16, 2024, JAGX opened at $0.15, traded as high as $0.26 and as low as $0.14, and closed at $0.18. Trading volume was a total of 616.38M shares. On April 17, 2024, JAGX opened at $0.18, traded as high as $0.21 and as low as $0.15, and closed at $0.17. Trading volume was a total of 133.95M shares. On April 18, 2024, JAGX opened at $0.14, traded as high as $0.18 and as low as $0.14, and closed at $0.18. Trading volume was a total of 69.32M shares. On April 19, 2024, JAGX opened at $0.16, traded as high as $0.17 and as low as $0.15, and closed at $0.16. Trading volume was a total of 30.39M shares.
JAGX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Jaguar Health shares, starting with a $10,000 purchase of JAGX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/13/2015 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$160,177.50 |
|
| End price/share: |
$0.16 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-100.00% |
|
| Average Annual Total Return: |
-78.72% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$0.01 |
|
| Years: |
8.94 |
|
|
|
| Date |
Close |
| 04/15/2024 | $0.12 | | 04/16/2024 | $0.18 | | 04/17/2024 | $0.17 | | 04/18/2024 | $0.18 | | 04/19/2024 | $0.16 |
|
|
Free JAGX Email Alerts:
